Suicidal ideation — broadly defined as thoughts, considerations, or plans relating to suicide — is among the more frequently encountered presentations in clinical practice, yet the healthcare workforce's readiness to address it remains inconsistent at best. A clinical update published in the BMJ draws together current evidence on how suicidal ideation should be assessed and managed in adults, and the picture it paints of clinician preparedness is a sobering one.
A Prevalent but Poorly Managed Presentation
The BMJ update describes suicidal ideation as highly prevalent across healthcare settings — not confined to psychiatric units or crisis services, but present throughout primary care, general hospitals, and beyond. Despite this, the guidance notes that most clinicians report inadequate training when it comes to both assessing and managing patients who present with such thoughts.
That gap between prevalence and preparedness is not a minor administrative concern. It has direct implications for patient safety, particularly given how many healthcare professionals will, over the course of a career, lose a patient to suicide.
How Many Clinicians Will Encounter a Patient Suicide?
A systematic review drawing on 41 studies conducted across 15 countries — cited in the BMJ update — examined the likelihood of clinicians experiencing a patient suicide during their working lives. The findings were striking. Among general practitioners, the figure reached 87%, meaning the vast majority of family doctors can expect to encounter at least one such loss. Among psychiatrists, the proportion stood at 73%, while across all health professionals combined, the estimate was 51%.
These are not rare events confined to high-acuity specialties. They represent a near-universal professional experience for GPs in particular — a group that may have less specialist training in suicide risk than their psychiatric colleagues, yet face the highest projected exposure.
Training Gaps Among General Practitioners
The training deficit is quantified more precisely by a 2018 cross-sectional study involving 208 general practitioners from across Europe, also referenced in the BMJ update. When asked about their comfort in assessing suicide risk, only 35% of respondents said they felt at ease doing so. Slightly more — 53% — reported having received some form of prior training in suicide prevention, covering areas such as detection and evidence-based treatment approaches.
That means nearly half of the GPs surveyed had received no formal training in this area at all, and nearly two-thirds did not feel comfortable with risk assessment. Given that GPs are often the first point of clinical contact for individuals experiencing psychological distress, these figures point to a structural gap in how healthcare systems prepare their workforces.
Who Is at Elevated Risk?
The BMJ update identifies several factors associated with increased likelihood of suicidal ideation. Psychiatric diagnoses feature prominently, as do age-related vulnerabilities at both ends of the spectrum — younger and older adults are each flagged as higher-risk groups. Female sex, physical disabilities, and marginalised social status are also cited among the recognised risk factors.
This breadth of risk factors underscores why suicidal ideation cannot be treated as a concern exclusive to mental health services. Physical health teams, geriatric care providers, and primary care practitioners all work with populations that carry elevated risk, reinforcing the case for broader training across clinical disciplines.
Screening: Targeted Rather Than Universal
On the question of screening, the BMJ update takes a measured position. No current clinical guidelines recommend universal screening for suicidal ideation across entire patient populations. Instead, the evidence supports a more targeted approach — screening those identified as being at elevated risk, based on the kinds of demographic and clinical factors outlined above.
This distinction matters in practice. Universal screening programmes carry their own logistical and clinical challenges, including the risk of false positives and the resource demands of follow-up. A risk-stratified model, by contrast, focuses clinical attention where the evidence suggests it is most warranted.
Treatment: Where the Evidence Points
Among the therapeutic approaches examined in the update, cognitive behavioural therapy (CBT) is identified as carrying the strongest evidence base for treating suicidal ideation in adults. CBT's structured approach to identifying and modifying thought patterns makes it a logical fit for a condition defined, in part, by the nature of the thoughts themselves.
The update does not position CBT as the only option, but its designation as the best-evidenced treatment reflects a body of research that has accumulated over decades. Other interventions exist, and clinical decisions will inevitably be shaped by individual patient circumstances, severity, and access — but CBT's standing in the evidence hierarchy is clear.
The Broader Picture
What the BMJ clinical update ultimately illustrates is a mismatch between the scale of the challenge and the resources — particularly in training — that healthcare systems have historically devoted to it. Suicidal ideation is not an edge-case presentation. It is something that the majority of GPs, and a substantial proportion of all health professionals, will encounter repeatedly throughout their careers.
The data on clinician discomfort and training gaps suggest that many are navigating these encounters without adequate preparation. A systematic review spanning 41 studies and 15 countries, alongside a targeted European GP survey, both point in the same direction: the clinical workforce needs more structured, evidence-based training in this area, not less.
Whether that training gap is addressed through undergraduate curricula, continuing professional development, or institutional policy is a question the update leaves to health systems to resolve. What the evidence does not leave in doubt is that the gap exists — and that it is wide.